Clazakizumab
Based on 1 Customer Validation
Clazakizumab (ALD-518; BMS-945429) is a monoclonal antibody inhibitor targeting IL-6 that binds to and blocks IL-6-mediated signaling (including trans-signaling), reducing STAT3 phosphorylation, innate immune cell infiltration, endothelial activation, and complement activation, thereby protecting the kidney from ischemia-reperfusion injury. Clazakizumab can be used in research on renal ischemia-reperfusion injury and obesity-related hypercoagulability.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : ≥99.0%
- CAS. Nr.: 1236278-28-6
- Molecular Weight:145.234 kDa
-
Speicherung:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
|
IL-6 |
STAT3 |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
-
Flow cytometric analysis of 1.5×106 Siha cells with Clazakizumab (HY-P99012, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Chemical Information
-
CAS. Nr. 1236278-28-6
-
Appearance Liquid
-
Molecular Weight 145.234 kDa
-
Color Colorless to light yellow
-
SMILES
[Clazakizumab]
-
Synonyms
ALD-518; BMS-945429
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
Data Sheet (267 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Clazakizumab
- 1236278-28-6
- ALD-518
- BMS-945429
- ALD518
- ALD 518
- BMS945429
- BMS 945429
- BMS-945429
- Interleukin Related
- STAT
- IL
- STAT3 phosphorylation
- trans-signalling
- endothelial cell activation
- interleukin-6 (IL-6)
- kidney
- glycocalyx shedding
- NGAL gene expression
- innate immune cell infiltration
- ischemia-reperfusion injury
- complement activation
- Inhibitor
- inhibitor
- inhibit